Financhill
Buy
52

PYPL Quote, Financials, Valuation and Earnings

Last price:
$60.06
Seasonality move :
-0.31%
Day range:
$59.31 - $60.15
52-week range:
$55.85 - $93.25
Dividend yield:
0.23%
P/E ratio:
12.05x
P/S ratio:
1.80x
P/B ratio:
2.78x
Volume:
5.5M
Avg. volume:
16.3M
1-year change:
-31.97%
Market cap:
$56.2B
Revenue:
$31.8B
EPS (TTM):
$4.98

PYPL Analysts' Consensus Rating

The 39 analysts providing 12-month price projections for PayPal Holdings, Inc. shares anticipate an average target of $78.48, ranging from a low estimate of $51.00 to a high estimate of $120.00. This average target implies a growth of 30.72% compared to the current stock price of $60.04.

Consensus Price Target

$78.48

Highest Price Target

$120.00

Lowest Price Target

$51.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 16 12 10

Hold 21 23 25

Sell 3 3 4
Consensus Hold Hold Hold

PYPL Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock